Exacerbation of coagulopathy with concurrent bone marrow necrosis, hepatic and renal dysfunction secondary to all-trans retinoic acid therapy for acute promyelocytic leukemia

Hematological Oncology

Volumn 15, Issue 1, 1997, Pages 13-17

  Cull, Gavin M ^a   Eikelboom, John W ^b   Cannell, Paul K ^b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

All trans retinoic acid; Bone marrow necrosis; Coagulopathy

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATININE; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; PREDNISOLONE; RETINOIC ACID;

ACUTE KIDNEY TUBULE NECROSIS; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BONE MARROW NECROSIS; CASE REPORT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FAILURE; LIVER CELL DAMAGE; LIVER DYSFUNCTION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; BLOOD COAGULATION DISORDERS; BONE MARROW; FEMALE; HUMANS; KIDNEY DISEASES; LEUKEMIA, PROMYELOCYTIC, ACUTE; LIVER DISEASES; NECROSIS; TRETINOIN;

EID: 0030928750     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(199702)15:1<13::AID-HON593>3.0.CO;2-S     Document Type: Article

References (11)

1. Grignani, F., Fagioli, M., Alcalay, M., et al. Acute promyelocytic leukaemia: from genetics to treatment. Blood 1994, 83, 10-25.
2. Warrell, R. P., Maslak, P., Eardley, A., et al. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid: an update of the New York experience. Leukaemia 1994, 8, 929-933.
3. Ohno, R., Yoshida, H., Fukutani, H., et al. Multi-institutional study of all-trans retinoic acid as a differentiation therapy of refractory acute promyelocytic leukaemia. Leukaemia 1993, 7, 1722-1727.
4. Fenaux, P., Le Deley, M. C., Castiagne, S., et al. Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukaemia. Results of a multicentre randomised trial. Blood 1993, 82, 3241-3249.
5. Huang, M., Yu-chen, Y., Shu-rong, C., et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukaemia. Blood 1988, 82, 567-572.
6. Castiagne, S., Chomienne, C., Daniel, M. T., et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukaemia. 1. Clinical results. Blood 1990, 76, 1704-1709.
7. Warrell, R. P., Frankel, S. R., Miller, W. H., et al. Differentiation therapy of acute promyelocytic leukaemia with tretinoin (all-trans retinoic acid). New Engl. J. Med. 1991, 324, 1385-1393.
8. Frankel, S. R., Eardley, A., Heller, G., et al. All-trans retinoic acid for acute promyelocytic leukaemia. Results of the New York study. Ann. Intern. Med. 1994, 120, 278-286.
9. Chen, Z. X., Xue, Y. Q., Zhang, R., et al. A clinical and experimental study on all-trans retinoic acid-treated promyelocytic leukaemia patients. Blood 1991, 78, 1413-1419.
10. Dombret, H., Scrobohacl, M. L., Ghorra, P., et al. Coagulation disorders associated with acute promyelocytic leukaemia: corrective effect of all-trans retinoic acid treatment. Leukaemia 1993, 7, 2-9.
11. Dreosti, L. M., Bezwoda, W., Gunter, K., et al. Bone marrow necrosis following all-trans retinoic acid therapy for acute promyelocytic leukaemia. Leuk. Lymph. 1994, 13, 353-356.